![4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride structure, CAS 184475-55-6](/structures/180000/171368_2_184475_55_6.png)
CAS Number184475-55-6
SynonymsGefitinib hydrochloride salt; 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline hydrochloride salt; X5007; Gefitinib hydrochloride; Gefitinib (hydrochloride)
Molecular FormulaC22H25Cl2FN4O3
Molecular Weight483.363
Purity98%%
Boiling Point607.7ºC at 760 mmHg
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 184475-55-6 |
| Catalog No. | 2A-1171182 |
| Chinese Name | Gefitinib hydrochloride |
| Synonyms | Gefitinib hydrochloride salt; 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline hydrochloride salt; X5007; Gefitinib hydrochloride; Gefitinib (hydrochloride) |
| Molecular Formula | C22H25Cl2FN4O3 |
| Molecular Weight | 483.363 |
| Purity | 98% |
| Boiling Point | 607.7ºC at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | Gefitinib hydrochloride is a potent EGFR tyrosine kinase inhibitor with IC50 values of 2-37 nM in NR6wtEGFR cells. |
| PubChem ID | 31643822 |
| SMILES | COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1.Cl |
| InChI | InChI=1S/C22H24ClFN4O3.ClH/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15;/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27);1H |
| InChI Key | QUINXWLATMJDQF-UHFFFAOYSA-N |
| Transport Info | Product name: Gefitinib hydrochloride |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole | 241479-73-2 | 2A-1171120 |
| 8-chloroiMidazo[1,5-a]pyrazine | 56468-23-6 | 2A-1171133 |
| (1R,2S)-2-Phenyl-cyclopropylamine hydrochloride | 37388-05-9 | 2A-1171146 |
| (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydr o-1H-cyclopenta[a]phenanthren-3-ol | 1224-94-8 | 2A-1171179 |
| 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline dihydrochloride | 184475-56-7 | 2A-1171181 |
| (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | 841205-47-8 | 2A-1171184 |
| (2R,6R)-Hydroxynorketamine | 1430202-69-9 | 2A-1171187 |
| (2S,4S)-(-)-2,4-BIS(DIPHENYLPHOSPHINO)PENTANE | 77876-39-2 | 2A-1171214 |
| (S)-3-METHYLHEPTANOIC ACID | 59614-85-6 | 2A-1171216 |
| (2S,3R)-N-BOC-2-AMINO-3-PHENYLBUTYRIC ACID | 145432-51-5 | 2A-1171230 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA